Teva Likes Biosimilar Licensing Deals As It Cuts Full-Year Sales Guidance

Recent Deal Brought In Bioeq’s Lucentis Biosimilar In Europe

 
• By Dean Rudge
  
Business Growth
Licensing deals 'will not be huge blockbusters' • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business